PUMA BIOTECHNOLOGY INC's ticker is PBYI and the CUSIP is 74587V107. A total of 89 filers reported holding PUMA BIOTECHNOLOGY INC in Q2 2022. The put-call ratio across all filers is 1.18 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $85,841 | -25.5% | 32,639 | 0.0% | 0.01% | -16.7% |
| Q2 2023 | $115,216 | +16.9% | 32,639 | +2.4% | 0.01% | 0.0% |
| Q1 2023 | $98,522 | -18.3% | 31,884 | +11.9% | 0.01% | -33.3% |
| Q4 2022 | $120,538 | +79.9% | 28,496 | +1.0% | 0.02% | +100.0% |
| Q3 2022 | $67,000 | -16.2% | 28,205 | 0.0% | 0.01% | -10.0% |
| Q2 2022 | $80,000 | -2.4% | 28,205 | -1.3% | 0.01% | 0.0% |
| Q1 2022 | $82,000 | -79.9% | 28,571 | -10.7% | 0.01% | -81.8% |
| Q2 2019 | $407,000 | -62.1% | 32,000 | +76.5% | 0.06% | -51.3% |
| Q2 2018 | $1,073,000 | -21.7% | 18,132 | +15.6% | 0.11% | -38.6% |
| Q2 2017 | $1,371,000 | +185.6% | 15,685 | +21.6% | 0.18% | +109.1% |
| Q1 2017 | $480,000 | – | 12,900 | – | 0.09% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| HARVARD MANAGEMENT CO INC | 600,000 | $45,216,000 | 3.56% |
| Avalon Global Asset Management LLC | 32,900 | $2,479,000 | 1.79% |
| CORNERSTONE CAPITAL MANAGEMENT LLC | 495,145 | $37,314,000 | 1.58% |
| BB BIOTECH AG | 521,991 | $39,337,000 | 1.25% |
| WEATHERBIE CAPITAL, LLC | 137,041 | $10,327,000 | 1.20% |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | 5,686,668 | $428,527,000 | 1.19% |
| TOBAM | 318,384 | $23,994,000 | 0.94% |
| Orbimed Advisors | 1,195,500 | $90,093,000 | 0.91% |
| Capital International Sarl | 109,405 | $8,245,000 | 0.74% |
| CAPITAL INTERNATIONAL LTD /CA/ | 145,697 | $10,980,000 | 0.73% |